NASDAQ:IOVA

Iovance Biotherapeutics Stock Predictions

etoro logo Buy IOVA
*Your capital is at risk
$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

IOVA Prediction Chart

IOVA Predictions History

Latest community submissions for IOVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 5, 2026 $2.59 +2.84% $2.45 X 94.22% 0
Jan 5, 2026 $2.56 +1.78% $2.45 X 95.31% 0
Jan 5, 2026 Bullish $2.45 X 0
Dec 31, 2025 $2.84 +2.47% $2.73 X 96.03% 0
Dec 31, 2025 $2.73 -1.54% $2.73 V 99.90% 10
Dec 31, 2025 Bullish $2.73 X 0
Dec 31, 2025 Bullish $2.73 X 0
Dec 30, 2025 $2.86 +2.48% $2.77 X 96.78% 0
Dec 30, 2025 $2.75 -1.55% $2.77 V 99.16% 3
Dec 30, 2025 Bullish $2.77 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for IOVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT IOVANCE BIOTHERAPEUTICS, INC.
Iovance Biotherapeutics
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE